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 Development of written information for antiretroviral therapy: Comprehension in 
a Tanzanian population 
 
Abstract 
Objective: To design and develop a simple, easily readable patient information leaflet 
(PIL) for a commonly used antiretroviral (ARV) regimen and to evaluate its readability 
and acceptability in a Tanzanian population. 
Method: A PIL incorporating simple text and pictograms was designed for the 
antiretroviral regimen of stavudine, lamivudine and efavirenz. The PIL was designed 
according to established good design guidelines, modified during a multi-stage iterative 
testing process and piloted in a South African Xhosa population. The PIL was made 
available in both English and Kiswahili. Sixty Tanzanian participants who were not 
taking ARVs were interviewed. They were asked to read the PIL in the language of their 
choice and were then asked a series of two-part questions; the first part required 
participants to locate the information in the PIL, after which they were asked to explain 
the information in their own words. Acceptability was assessed through close-ended 
questions and open-ended feedback. The influence of selected patient characteristics on 
comprehension of the PIL was investigated using regression analysis with a significance 
level set at 0.05.  
Main outcome measure: Comprehension of the written information was determined by 
calculating an overall percentage understanding. 
Results: The overall average percentage comprehension of the PIL was 95%. The target 
set by the EC guideline that at least 80% of participants correctly locate and understand 
the information was achieved for 19 of the 20 questions. Five of the six instructions  
Written information for antiretroviral therapy 2
illustrated by pictograms were correctly comprehended by all participants. The only 
patient characteristics significantly associated with comprehension were educational 
level and self-reported ease of reading the PIL. Acceptability of the PIL was high and 
positive comments were associated with simplicity, good design, easy readability and 
user-friendliness, the latter enhanced by the inclusion of pictograms. 
Conclusion: The PIL designed for this study was shown to be effective in 
communicating information about ARVs. Patient characteristics must be taken into 
account when developing written information, and the final document must be tested for 
comprehension in the target population. 
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Impact of our findings on practice 
? Be sensitive to the problems patients may encounter reading and understanding 
written medicines information and ensure that the information can be adequately 
comprehended. 
? Much of the currently available medicines information is too complex, 
particularly for patients with limited reading skills. 
? Use written information as a complement to verbal consultation, to reinforce 
advice and orally communicated information and to aid recall of pertinent 
information. 
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? Consider the characteristics of the target population when developing information, 
test it for comprehension in the target population, and make it available in the first 
language of the patients. 
? Limit the information to be included, excluding information such as technical 
product details and focus on writing for desired health behaviour, rather than for 
high-level knowledge. 
 
 Introduction 
Written medicines information is recognised as an integral component of patient 
education, supporting patients’ participation in decisions about strategies to manage 
their health problems and to promote safe and effective medicine-taking behaviour1. 
Most commercial patient information leaflets (PILs) are written according to a closely 
controlled legislated format where minimal deviation being allowed2, and although 
considerable effort is put into developing such materials, their design mostly reflects the 
health professional and/or the manufacturer perspective, with little focus put on the 
patient perspective and patient-related factors such as health literacy level, culture, 
health beliefs, needs and opinions3-6. Much evidence exists that patients do not receive 
the information they both want and need, and therefore written information can play an 
important role in supplementing and reinforcing verbal information provided by health 
care providers1,7. However, if patients are to be active participants in decisions about 
their care, the information they are given must be evidence-based and presented in an 
acceptable, comprehensible and useful form. To ensure comprehensibility and 
relevance, testing in the target population is essential1,4,8. 
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In an excellent review on patients’ processing of written information, Morris and Aikin9 
emphasize the importance of the interaction between the patient and the materials, a 
relationship that is severely compromised by limited reading skills, influencing both 
visualization of the page and the subsequent information processing tasks. 
Simplification of the material may help poor readers in decoding the text. 
 
Research has consistently shown that health-related educational materials are generally 
written at reading levels significantly higher than the reading comprehension levels of 
most patients7,10-12. Much of the research has originated from the US, where a recent 
report released by the Institute of Medicine indicates that nearly half of the adult 
population in the US (90 million people) may have trouble understanding and acting on 
health information13.  However, irrespective of their educational level, people generally 
prefer simple and easy-to-read materials8 and find it easier in the clinical situation to 
comprehend and act correctly on short, simple messages than on more complex ones14. 
Medicines information intended for patients should therefore be written in the simplest 
form possible for optimal acceptance and comprehension4,12. 
 
Over the past decade, growing evidence has revealed the magnitude and consequences 
of limited literacy on the health and health care of many patients at risk. Literacy has 
been reported as a stronger predictor of health than is level of education, being linked to 
delays in accessing and using preventive services, adherence to medical instructions, 
compromised self-care skills and poorer health outcomes15. In developing countries, 
limited literacy is more prevalent, with figures from UNESCO giving the sub-Saharan 
Africa adult literacy rate as only 59.8% compared with 98.7% in North America and 
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Western Europe16. This widespread lack of literacy skills in an increasingly complex 
health care environment has a seriously negative impact on health. 
 
HIV/AIDS in Tanzania 
 
An estimated 40 million people are currently infected with HIV worldwide17. Sub-
Saharan Africa is the most severely affected region in the world with an estimated 25.8 
million HIV-positive people17. In Tanzania a total of 1.6 million people, representing an 
HIV national prevalence rate of 7%, are living with HIV/AIDS. The Tanzanian national 
antiretroviral (ARV) treatment plan was established in October 2004, where the 
government established the aim of having 44 000 patient on ARVs by the end of 200518.  
According to unpublished data obtained from a representative from the National Aids 
Control Programme (NACP) in Tanzania, as of January 2006, 25 000 patients were 
receiving ARVs and the new target set for 2006 is to have 100 000 patients on ARVs by 
the end of the year. The management of AIDS using ARVs constitutes chronic, complex 
therapy that demands extremely high adherence levels above 95%, as poor adherence 
has been associated with the development of resistance and ultimate therapy failure19. 
Written medicine information was identified as one of the key components in a 
medication self-management program to improve adherence to ARVs19. 
 
Research objectives 
 
The objectives of this project were to design and develop a simple, easily readable PIL 
for a commonly used ARV regimen and to evaluate its readability as well as its 
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acceptability in a Tanzanian population. An additional objective was to determine the 
influence of selected patient variables on comprehension of the leaflet. 
 
Method 
 
Study site and study population  
 
The study was conducted in Dar-es-Salaam, Tanzania, which is a poor country with an 
adult literacy rate of 69.4% and an estimated total of 6 million illiterate adults16. The 
study population consisted of 60 Tanzanian participants of different tribes and 
educational levels. Eligibility criteria included being at least 18 years old, and the ability 
to read either Kiswahili or English. Exclusion criteria for participants included a 
diagnosis of HIV/AIDS and currently taking ARV therapy. Approval for the study was 
obtained from the Muhimbili University College of Health Sciences, School of 
Pharmacy Departmental Ethical Standards Committee.  
 
 
Research materials 
 
A PIL was developed for the ARV regimen of stavudine, lamivudine and efavirenz 
using a variety of published guidelines on patient information design8,20-24. Particular 
attention was paid to the use of simple words, the avoidance of medical jargon and the 
inclusion of short sentences. Complex, multi-syllable words and medical jargon were 
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avoided wherever possible and were substituted with linguistically transparent words 
and commonly used phrases that were more familiar to the target population.  
 
The information included was carefully considered in order to limit the overall length of 
the document. Short sentences were used, and a three-column format adopted24. An easy 
to read font in an appropriately large font size (Arial 10 point) was used for the text24. 
Text was broken up into short blocks thus avoiding large, dense blocks of text which are 
intimidating to poorer readers, and adequate white space was included.  Headings, an 
essential feature contributing to successful navigation through the PIL, were emphasized 
by using a bold, larger font size (Helvetica 14 point, bold) and including a line border 
above and below the text. The active voice was used throughout, and bullet points made 
multiple points easier to read.  
 
In an attempt to enhance comprehension and promote acceptability, a total of six 
pharmaceutical pictograms from a number of sources25,26 were modified, tested27 and 
incorporated into the text. The initial developmental phases and pilot testing of the PIL 
occurred in a South African Xhosa population27. The two-page A4-size PIL was 
subjected to Fry’s readability test28 and was found to be suitable for Grade 7 learners. 
The final English version of the PIL (Figure 1) was translated into Kiswahili using a 
multistage translation approach.   
 
Recruitment, interview process and data collection 
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A standardized approach was adopted for recruitment and interviewing. The researcher, 
whose first language is Kiswahili, emphasized that this study aimed to assess the quality 
and usefulness of the PILs, rather than testing the participants’ reading skills.  
 
Demographic data including gender, age, educational level and employment status were 
collected to investigate a possible relationship between these characteristics and 
comprehension of the PIL. Participants were shown the PIL in both English and 
Kiswahili and read the version of their choice at their own pace. The time taken to read 
the PIL was recorded. The process used for evaluating the PIL was based on that 
pioneered by the Communication Research Institute of Australia20. Participants were 
asked 20 two-part questions; firstly, they were required to locate the information in the 
PIL, and secondly, to explain it using their own words in order to evaluate 
comprehension. Acceptability of the PIL was investigated by asking a number of close-
ended questions as well as encouraging open-ended feedback. At the conclusion of the 
interview, participants were offered a small honorarium.   
 
Data analysis 
 
An understanding score for the PIL was calculated based on the number of questions of 
the total 20 questions answered correctly. Understanding was evaluated using the 
European Commission (EC) guideline21 setting a minimum of 80% of correct answers 
as a target, including locating the information and the ability to explain it in their own 
words. The influence of selected patient characteristics on comprehension of the PIL 
was investigated using one-way ANOVA and t-tests for independent samples with a 
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significance level set at 0.05. Scheffé multiple comparison test procedure and Levene’s 
test were used to test for pairwise differences and homogeneity of the variances, 
respectively. Characteristics investigated included gender, age, educational level, 
employment status, self-reported ease of reading the PIL and frequency of medicine 
taking. In all analyses, homogeneity of the variances was attained after arcsin (√(PIL 
%/100) transformation (P > 0.01). 
 
 
Results 
 
Demographic characteristics 
 
Insert Table 1 here 
The demographic characteristics of the 60 participants are presented in Table 1. There 
was a fairly equitable distribution of gender and a majority of participants aged between 
21 and 40 years. Three participants attended school for less than five years, the majority 
(60%) had between 5 and 11 years of formal education and a third of the sample more 
than 11 years of formal education.  The majority of the sample (65%) were employed at 
the time of the study. Given that purposive sampling was employed in this study, these 
figures are not an accurate representation of the general Tanzanian population. 
 
Understanding of the PIL 
 
The average time taken to read the PIL was nine minutes. Almost half (48%) took 
between 5 and 10 minutes to read the PIL and 35% took between 10 and 15 minutes. 
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The average percentage understanding of the PIL displayed by all participants was high 
(95%). Table 2 illustrates the degree of success with which the information for each 
individual question was located and understood. The target set by the EC guideline was 
achieved for 19 of the 20 questions. Five of the six instructions that were illustrated by 
pictograms were correctly comprehended by all 60 participants.  
Insert Table 2 here 
Question 3 was the most poorly answered question and yielded interesting results as 
93% were able to locate the information on the consequences of not taking the medicine 
as instructed, but only 65% could explain these consequences in their own words. 
Eleven of the 60 participants were unable to either locate or understand the information 
concerning chronic usage of ARVs (Question 11). 
 
The researcher closely observed participants locating information in the PIL, where 40 
of the 60 participants used the headings in the PIL appropriately to help locate the 
information. Generally the poorer readers scanned the PIL in a more random manner, 
did not use the headings, and took longer to locate the information. Most of the words in 
the PIL were understood. Words or phrases that presented particular problems included 
antiretroviral (80% correct), CD4 count (75% correct), pharmacist (38% correct) and 
capsules (8% correct).  
 
Acceptability of the PIL 
 
The physical appearance of the PIL appealed to the majority of the participants (Table 
3). Only 5 of the 60 participants classified it as ‘difficult’ to read, whereas just under a 
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third considered it ‘easy’ to read. The general consensus was that the font size (Arial 10 
point) was satisfactory, the length of the sentences was suitable and there was sufficient 
‘white space’ in the document. Mention was also frequently made of its simplicity, good 
design, easy readability and user-friendliness which was enhanced by the inclusion of 
pictograms. All participants expressed their approval for incorporating pictures in the 
PIL and were of the opinion that the pictures would contribute to better understanding 
and enhanced recall of the information. 
Insert Table 3 here 
Most participants felt that the PIL was comprehensive enough to adequately inform 
medicine taking behaviour, although a number stated that they would like to have more 
detailed information after using these medicines for a period. All participants stated that 
they would prefer to receive PILs in their first language (Kiswahili).   
 
The product description section in the PIL elicited many negative comments and was 
not understood or liked by the majority of participants. In their opinion, it did not 
constitute important patient-centred information, was too technical and had of no value 
in informing medicine taking behaviour.  
 
Association between comprehension and patient characteristics 
 
No significant association was found between the overall percentage understanding of 
the PIL and patients’ gender, age, employment status and frequency of medicine taking 
(t-test: gender: t=1.3, 58 df, P=0.3729; employment: t=0.6, 58 df, P=0.4276; ANOVA: 
age: F=1.7, (2, 57) df, P=0.1987; medicine taking: F=1.0, (3, 56) df, P=0.4076). Men 
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and women displayed a similar comprehension of the PIL, as did both employed and 
unemployed Tanzanians. The lack of a significant age effect appears to be surprising, as 
literacy skills are generally lower in populations over the age of 60 years8. However, 
none of the participants were older than 65 years and only 6 (10%) were older than 40 
years. This number is likely to have been too low to detect a significant difference. 
Educational level, as may be anticipated, was found to influence comprehension 
significantly (ANOVA: F=5.1, (2, 57) df, P=0.0096; Scheffé: 0-5 years significantly 
different from 6-11 and >11 years).  Participants were asked to rate the difficulty of 
reading the PIL (either as “easy”, “average” or “difficult”). This variable was also found 
to influence comprehension significantly with comprehension, a fairly predictable 
finding supported by existing literature3 (ANOVA: F=8.7, (2, 57) df, P=0.0005; 
Scheffé: “difficult” level significantly different from “easy” and “average” levels). 
 
Discussion 
 
The two-page PIL containing information on the combined triple ARV regimen 
developed and tested in this study was found to be suitable for Grade 7 readers and was  
shown to be an effective communication tool, with an average 95% comprehension rate 
being achieved. Factors contributing to its success include the design process which 
took into account established design principles, insight into the literacy skills of the 
intended readers which influenced content and layout of the document, and the multi-
stage iterative testing and modifying process. 
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Variations in numerous design features of documents may influence text processing9 
and were taken into account when designing this PIL. Another significant strategy in 
promoting the usefulness and acceptability of written information is to make it available 
in the patient’s first language or language of choice6,7 and this was considered to be a 
key factor in the success of this PIL. All the Tanzanian participants in this study chose 
to read the PIL in their first language (Kiswahili) and considered it essential that PILs be 
made available in the readers’ first language, particularly in multilingual societies.  
 
The incorporation of pictograms in this ARV PIL promoted the user-friendly appeal and 
assisted with the location of selected information. Research shows that adding pictures 
to written information can increase patient attention, comprehension, recall and 
adherence4,5,7,29. Mansoor and Dowse4 found that in 60 low-literate South Africans, 
medicines information incorporating pictures was significantly better comprehended 
than documents containing text only, and it was the preferred format. Our results concur  
with these findings as the presence of pictograms in the PIL elicited universal positive 
comments and the illustrated instructions were  well comprehended.      
 
Although the PIL was generally well comprehended, specific problem areas were 
identified which require attention. The inability to explain information that was located 
(e.g. Question 3) may have been due to the complex phrasing of the question, as well as 
inadequate explanation in the PIL. Lack of familiarity with the information content (i.e. 
the development of resistance as a result of inappropriate medicine usage) probably also 
contributed to this poor comprehension.  
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Of particular concern was the lack of understanding by 11 participants of the 
information relating to chronic ARV usage. This is central to a long-term successful 
health outcome and indicates that, in patients unfamiliar with ARV therapy, this 
information should appear more prominently in the PIL. Other important HIV/AIDS-
related information that results indicate should be emphasized, is the necessity of 
continuing to take precautions in sexual encounters while taking ARVs as they offer no 
protection against the danger of infecting others (Question 2). Terms such as 
‘antiretroviral’ and ‘CD4’, although unknown to some participants, are terms that 
should rapidly become familiar to people taking ARVs.  
 
Despite the relative simplicity of the document, the 2-page length remained daunting to 
those participants with poorer reading skills who took longer than 10 minutes to read it. 
In practice, patients with lower literacy may not persist in reading a document of this 
length. Legislators should take note of the patient perspective when deciding on 
required information for inclusion in PILs. Similar to findings by Howard et al.2, 
participants of this study attributed little importance to the product information section, 
considering it irrelevant and difficult to read, while adversely affecting the overall 
length of the document. 
 
A limitation of the study was that the PIL was not tested on patients taking ARVs, and 
therefore participants generally had no personal interest in the information. Results from 
testing this PIL in people with HIV/AIDS taking ARVs may therefore differ, and this 
should be further investigated. However, the usefulness of testing in these HIV-naïve 
participants is the insight it affords into under-explained knowledge areas which can 
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then inform developers of HIV/AIDS information. The sample size was relatively small 
and only included participants from one country and one language group in eastern 
Africa. The results, therefore, cannot be extrapolated to other African countries.  
 
Conclusions 
 
Minimal written medicines information is available to patients in sub-Saharan Africa as 
few of the countries in this region have legal requirements for the provision of PILs. 
This study showed that medicines information designed and tested according to good 
practice guidelines, taking patient characteristics into account, was successful in 
communicating essential information to guide appropriate medicine taking behaviour in 
people taking ARVs. Given that Tanzania has an estimated 6 million illiterate adults16, 
many Tanzanians may therefore benefit from PILs designed in accordance with their 
reading skills, written in their first language and including pictorial explanations. The 
approach to developing the leaflet and the PIL design template used in this study forms 
a sound basis for extending the work to additional drug groups and to other African 
populations.  
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Table 1 Demographic characteristics (n= 60) 
 
 Participants, n (%) 
Gender 
 Male 
 Female 
Age (years) 
 < 21 
 21 – 40 
 41 – 65 
Years of formal education 
 0 – 5 
 6 – 11 
 > 11 
Employment status 
 Employed 
 Unemployed 
 
27 (45.0) 
33 (55.0) 
 
18 (30.0) 
36 (60.0) 
  6 (10.0) 
 
  3 (5.0) 
37 (61.7) 
20 (33.3) 
 
39 (65.0) 
21 (35.0) 
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Table 2 Number (%) of participants correctly locating and understanding 
   information in the PIL. 
 
Questions 
Participants 
n (%)  
1. Using the leaflet, can you tell me the name of these medicines  
 and describe them? 
Located 60 (100.0) 
2. Can one still spread HIV/AIDS while taking these medicines? Located 
Understood 
56 (93.3) 
53 (88.7) 
3. If you do not take your medicines as instructed, what may 
 happen? 
Located 
Understood 
56 (93.3) 
39 (65.0)a
4. According to the leaflet, how many times a day must you take 
 Stavudine (d4T) capsules 
Located 
Understood 
60 (100.0) 
60 (100.0) 
5. Looking at the leaflet, does it tell you what to do if you miss a 
 dose of your medicines?   
Located 
Understood 
56 (93.3) 
55 (91.7) 
6. Like any other medicines, these medicines have both good and 
 bad effects. Does the leaflet tell you what the bad effects are 
 and what you should do if you experience any of them? 
Located 
Understood 
60 (100.0) 
60 (100.0) 
7. What do these medicines do to the viral load? Located 
Understood 
60 (100.0) 
59 (98.3) 
8. What does the leaflet tell you to do if you take too much of 
 these medicines by mistake? 
Located 
Understood 
53 (88.3) 
53 (88.3) 
9. Do these medicines cure HIV/AIDS? Located 
Understood 
60 (100.0) 
58 (96.7) 
10. According to the leaflet, if you are taking any other       
 medicines, what should you do before taking these 
medicines? 
Located 
Understood 
60 (100.0) 
60 (100.0) 
11. How long do you have to take these medicines for? Located 
Understood 
49 (81.7) 
49 (81.7) 
12. According to the leaflet, if you have any allergies, what 
should  you do before taking these medicines  
Located 
Understood 
60 (100.0) 
60 (100.0) 
13. Does the leaflet tell you how many of Efavirenz (EFV) 
 capsules you should take each time? 
Located 
Understood 
59 (98.3) 
59 (98.3) 
14. Suppose you have been feeling better for the past month; Can 
 you stop taking your medicines? 
Located 
Understood 
52 (86.7) 
52 (86.7) 
15. What should you do with left over medicines? Located 
Understood 
57 (95.0) 
57 (95.0) 
16. Some medicines can be taken with alcohol. Can you take 
 alcohol while taking these medicines? 
Located 
Understood 
60 (100.0) 
60 (100.0) 
17. Does the leaflet tell you how to store these medicines? Located 
Understood 
60 (100.0) 
60 (100.0) 
18. Is there any advice in this leaflet about sharing your 
medicines  with someone else who has HIV/AIDS? 
Located 
Understood 
59 (98.3) 
58 (96.7) 
19. Does it matter if you take these medicines at different times 
 every day? 
Located 
Understood 
58 (96.7) 
59 (98.3) 
20. If you want more information about your treatment and  
 medicines you are taking, who should you talk to? 
Located 
Understood 
59 (98.3) 
59 (98.3) 
Overall average percentage understanding of the PIL : 95%                                         
a Questions that failed to reach the EC target of 80% 
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Table 3 Acceptability of the PIL 
 
Questions 
Response Participants 
n (%) 
Readability 
How easy was it to read this leaflet? Easy 
Average  
Difficult 
18 (30.0) 
37 (61.7) 
  5 (8.3) 
Is the writing large enough? Yes 
No 
60 (100.0) 
  0 (0.0) 
What do you think of the length of the sentences? Too long 
Right 
Too short 
  2 (3.3) 
58 (96.7) 
  0 (0.0) 
Is there enough space between the lines? Too wide 
Right size 
Too small 
  4 (6.7) 
55 (91.7) 
  1 (1.7) 
Amount of information 
If you had just started taking these medicines and this 
was all the information you were given about them, 
do you think it is enough? 
Yes 
No 
58 (96.7) 
  2 (3.3) 
Pictograms 
Do you like having pictures in the leaflet?    Yes 
No 
60 (100.0) 
  0 (0.0) 
Do you think the pictures will help you 
 understand and recall the information better? 
Yes 
No 
60 (100.0) 
  0 (0.0) 
Words in the text 
Are there any words in the text that you did not 
understand? 
No 
Yes, a few 
Yes, many 
 10 (16.7) 
50 (83.3) 
  0 (0.0) 
PIL language preference 
In what language would you prefer to read the 
leaflet? 
English 
Kiswahili 
  0 (0.0) 
60 (100.0) 
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